Calista Therapeutics Inc

Biotechnology company · Lincoln, Rhode Island, United States

Calista Therapeutics Inc is a biotechnology company headquartered in Lincoln, Rhode Island, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $697,541 in total, most recently in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Calista Therapeutics at a glance

Typebiotechnology company

HeadquartersLincoln, Rhode Island, United States

Employees (self-reported, 2021)1

What does Calista Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $697,541 in total (2013 to 2021). NIH funding came from the National Eye Institute.

Frequently asked questions about Calista Therapeutics

Where is Calista Therapeutics headquartered?

Calista Therapeutics Inc is headquartered in Lincoln, Rhode Island, United States.

What does Calista Therapeutics do?

Calista Therapeutics Inc is a biotechnology company.

Similar companies

Adjuvance Technologies Inc.Lincoln, Nebraska, United States
LI-COR, Inc.Lincoln, Nebraska, United States
In Cytu, Inc.Lincoln, Rhode Island, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences